Figure 6From: Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomasPRDM2 showed a synergy effect with BRC on the inhibition of PRL secretion and MMQ cell viability. A: The PRL level of MMQ cells after PRDM2 and BRC. *compared to Control group # compared to BRC group B: The cell viability of MMQ cells after PRDM2 and BRC. *compared to Control group # compared to PRDM2 group.Back to article page